|
 Email
us
|
2006
Annual Meeting |
Announcements
|
|
- Our Brochure
-
Call
for Abstracts
-
Sponsorship/Exhibit
-
Our
2006 Supporters
-
IN THE SPOTLIGHT:
Intervention in Aging and Age-Related
Skin Diseases
|
-
Welcome to our AGE New Members!
-
Grant Announcements
|
|
35th AGE ANNUAL MEETING
- June 2-5, 2006 |
|
MEETING BROCHURE
Our new meeting brochure (including our
preliminary program, details on registration
and accommodation, speakers, etc.) is
available as a PDF download (see red box to
the right). All members should have received a
mailed copy
of it.
CALL FOR
ABSTRACTS
|
A month and
a half to the abstract submission deadline! |
Participants who wish to make an oral or a
poster presentation at this meeting must
submit an abstract which will be reviewed by
the Scientific Committee. Results of this
review will be communicated via email, to
each applicant. Please note that only
the abstract of the registered presenters
will be included in the program and the
Conference Handbook.
Submission deadline is March 15, 2006.
To submit your abstract today,
click here.
EXHIBIT/SPONSORSHIP
The 35th
American Aging Association Annual
Meeting offers great
opportunities to expand your
company's visibility among the
registrants by becoming an exhibitor
and/or conference sponsor.
These will include multiple
opportunities to:
- introduce and discuss your
products and services with
leading basic science
researchers and clinicians of
the aging field
- reach decision makers
within a group-setting
-
open door to
new leads and
long-term business relationships
- increase exposure and
strengthen brand recognition
in the aging research field.
Attendees include many decision
makers, such as academic department chairs,
heads of laboratories, government
officials, attending
clinicians, private practitioners,
post-docs, MD and PhD students and
technicians.
You will be hard pressed to
find a more appropriate audience for
your latest products and services.
Consider becoming a sponsor today and
take advantage of extensive
advertising opportunities via our
newsletter and website!
OUR SUPPORTERS
The 35th American
Aging Association Annual Meeting Organizers
are most grateful for the support of the
following organizations:
back |
|
ANNUAL MEETING SESSION SPOTLIGHT |
|
Following the first four presentations (see
our
September issue on
Sarcopenia: Cause, Effect
and Treatment, the
October
issue on Immunity and Infection,
the
November issue on the Pre-Meeting
Symposium on Caloric Restriction
and
December issue on
the Current
Advances in Understanding the Basic
Biology of Aging, we are continuing our
series with a brief presentation of the session on
Intervention in Aging and Age-Related
Skin Diseases
chaired by Dr. Barbara A. Gilchrest
(scheduled for Sunday, the 4th of
June, 2006). As
always,
we encourage your comments and questions.
Intervention in Aging
and Age-Related Skin Diseases
CHAIR:
Barbara
A. Gilchrest, MD
 Barbara
A. Gilchrest, MD - Dr.
Gilchrest received her
bachelor's degree in
Mathematics from the
Massachusetts Institute of
Technology in 1967 and
graduated cum laude from the
Harvard Medical School in
1971. She completed two
years of clinical training
in internal medicine and
three years of dermatology
residency, including a one
year photobiology fellowship
with Drs. Thomas Fitzpatrick
and John Parrish, in the
Harvard-affiliated
hospitals. She concluded
her training with a
laboratory-based research
fellowship at MIT. In
1977 Dr. Gilchrest joined
the Department of
Dermatology and Division on
Aging at the Harvard Medical
School, where she
established a tissue culture
laboratory to study aging
and photoaging in human
skin, with support from the
National Institute on
Aging. In 1983 Dr.
Gilchrest joined the USDA
Human Nutrition Research
Center on Aging at Tufts
University, as Chief of the
Cutaneous Gerontology
Laboratory to continue and
expand her work on skin
aging/photoaging. In
1985 Dr. Gilchrest was
appointed Professor and
Chairman of Dermatology at
the Boston University School
of Medicine and
Dermatologist-in-Chief at
the Boston Medical Center,
where her clinical practice
focuses on laser therapy and
prevention of skin cancers
through sun avoidance and
retinoid and photodynamic
therapy of severely
sun-damaged skin. Dr.
Gilchrest's laboratory-based
research involves cellular
responses to ultraviolet
(UV) irradiation, the
molecular basis of aging,
and melanogenesis
(pigmentation), particularly
UV-induced melanogenesis or
tanning. Most recently, her
group has focused on the
role of telomere-initiated
DNA damage responses in
intrinsic aging, photoaging
and other innate cancer
avoidance mechanisms.
Recently, she has
demonstrated that
telomere-homolog
oligonucleotides applied
topically to skin can induce
tanning, enhance DNA repair
capacity, reduce
photocarcinogenesis, and
otherwise mimic these
protective responses in the
absence of actual DNA
damage, a promising and
completely novel approach to
skin cancer prevention and
treatment. She is also
co-director of the joint
BU/Tufts dermatology
residency program and
director of an NIH-sponsored
post-doctoral research
training program. Dr.
Gilchrest is the author of
over 400 scholarly articles,
reviews, abstracts, and
textbook chapters; and
author or editor of eight
books. She is a past
President of the Society for
Investigative Dermatology,
of the Women’s Dermatologic
Society, and the Association
of Professors of
Dermatology. Dr. Gilchrest
has also served as a
Director of the American
Board of Dermatology
(1986-96), on the Board of
Directors of the American
Academy of Dermatology
(1995-99) as well as the
societies listed above; as
associate editor or
editorial board member of
several major clinical and
research journals; as an NIH
consultant, study section
and council member, member
of the MIT Corporation, and
presently on the Board of
Scientific Counselors for
the National Cancer
Institute; and as a
consultant or scientific
advisory board member for
large pharmaceutical
companies and biotechnology
start-up companies. She is
a member of the Institute of
Medicine of the National
Academies of Science.
SESSION
BACKGROUND
Intervention in
Aging and Age-Related Skin Diseases
Skin
aging has been a cosmetic concern
since the beginning of recorded
history. It has also long been
recognized that aged skin has
specific vulnerabilities and
associated diseases. The
pathogenesis of these changes and
disease predispositions remained
poorly understood, however, until
recently. In this session Dr. Mina
Yaar will discuss recent advances in
telomere biology that provide
insights into signaling pathways
that contribute to aging and
photoaging in the skin. Dr. Sewon
Kang will review extensive studies
into the physiologic role of
retinoic acid in skin aging and the
ability of topically applied
retinoic acid to prevent acute sun
damage and presumptively the chronic
process of photoaging, as well as to
reverse already established aging
and photoaging changes in skin. In
the final presentation, Dr. Peter
Elias will describe the
age-associated physical and chemical
changes in the protective outer
layer of skin, the stratum corneum,
that compromise its barrier function
and will propose therapeutic
approaches based on this
pathophysiology to improve barrier
function in the elderly. Overall,
the session will provide an
appreciation of the rapid advances
now being made in cutaneous
gerontology.
|
The Role of
Telomere-Based Signaling
in Skin Aging/Photoaging
|
Mina Yaar |
|
The Role of Retinoids in
Preventing and Treating
Skin Aging Changes |
Sewon Kang |
|
Mechanisms and
Consequences of
Age-Associated Changes
in the Skin Barrier |
Peter Elias |
<>SESSION SPEAKERS
 Peter
M. Elias, MD,
University of California,
San Francisco
-
Dr. Elias is a Staff
Physician and Chief,
Dermatology Research Unit,
VAMC-San Francisco, and head
of a multidisciplinary
research group, focused on
the research subjects listed
above. He has ongoing
extramural funding from the
NIH, the VA, as well as from
industry. He is a member
(elected), American Society
of Clinical Investigation
and American Association of
Professors; William Montagna
Award, Society of
Investigative Dermatology
(2001); Literature and
Maison G. de Navarre Awards,
Society for Cosmetic
Chemists; Robert Chesebrough
Award for Research (1992);
Irvin H. Blank Memorial
Lecturer, Harvard University
(2002); George Odland
Lecturer, University of
Washington (2003); editorial
board of several journals of
clinical and investigative
dermatology; author of 350
peer-reviewed; 50
chapters/books; and over 400
abstracts.
 Sewon
Kang, MD, University of
Michigan School of Medicine -
Dr. Kang is Professor and
Director of the Clinical
Pharmacology Unit of the
Department of Dermatology at
the University of Michigan
in Ann Arbor. He graduated
with honors from Williams
College (B.A.) and the
University of Michigan
(M.D., M.P.H.) and completed
his dermatology residency
and fellowship at the
Harvard Medical School /
Massachusetts General
Hospital. Dr. Kang is a
recipient of the Dermatology
Foundation Clinical Career
Development Award, and has
received other research
awards and grants from the
American Dermatological
Association, the National
Psoriasis Foundation and the
National Institutes of
Health (RO1, T32 and K24).
Internationally noted for
his work in the
pathogenesis, prevention and
treatment of photoaging, Dr.
Kang's expertise extends to
the therapeutic uses of
retinoids in the treatment
of acne and psoriasis, and
the use of phototherapy in
the treatment of
scleroderma.
 Mina
Yaar, MD, Boston University
School of Medicine - Dr.
Yaar
graduated from the Hebrew
University Hadassah Medical
School in 1978. She
completed three years of
laboratory based research
fellowship at the National
Institutes of Health in
Bethesda MD., and three
years of clinical training
in the combined Dermatologic
Residency Program of Boston
University/Tufts University
in Boston, MA.
In 1984 Dr. Yaar joined the
USDA Human Nutrition
Research Center on Aging at
Tufts University, as a
Research Associate in the
Cutaneous Gerontology
Laboratory and set off her
work on skin aging/photoaging.
In 1991 Dr. Yaar Joined the
Department of Dermatology at
the Boston University School
of Medicine and in 1995
became a Professor of
Dermatology. Dr. Yaar’s
laboratory based research
involves cellular responses
to ultraviolet irradiation,
the molecular basis of
aging/photoaging and DNA
damage responses in skin
derived cells. Dr. Yaar
serves on the editorial
board of the Journal for
Investigative Dermatology
and the Journal of Cutaneous
Medicine and Surgery.
Wish to contact any of the speakers or
comment on this session? Click here.
back |
|
ANNOUNCEMENTS |
|
WELCOME TO OUR NEW AGE MEMBERS:
Amina Akoulouze
Bika, PhD -
SCIENTIFIC MEMBER
- UTHSCSA
Richard Cawthon,
PhD - SCIENTIFIC MEMBER - University of
Utah
If we
had omitted your name from this list of new
members,
please let us know.
back |
|
Click here to support AGE with $35 OR MORE
FOR
ITS 35 SUCCESSFUL YEARS! |
|
GRANT
ANNOUNCEMENTS:
2006 Barry
Reisberg Award for Non-Pharmacologic Research,
Theory, and Clinical Practice
Deadline: March 1, 2006
The Hearthstone Alzheimer's Family Foundation, a
501C-3 not for profit organization, is seeking
nominations for the 2006 Barry Reisberg Award
For Non-Pharmacologic Research, Theory, and
Clinical Practice
www.thehearth.org/Foundation/Reisberg%20Award.htm
. In addition to a monetary prize, the Honoree
is expected to present a lecture at the public
awards ceremony in New York City during the
month of May.
Founded in 1995, by Drs. Joan Hyde and John
Zeisel, internationally recognized experts in
the field of non-pharmacologic treatment for
people living with Alzheimer's disease, the
Hearthstone Alzheimer's Family Foundation
promotes primarily non-pharmacologic approaches
to treatment for the millions of people coping
with Alzheimer's. The Foundation's mission is to
develop approaches to care and treatment that
coordinate non-pharmacologic with pharmaceutical
treatment to address the complex needs of this
growing population and their care partners.
Non-pharmacologic treatments that are believed
to improve health outcomes include environmental
design, therapeutic gardens, caregiver
communication training, family awareness, family
participation in caregiving, alternative health
care, diet, exercise, music, and art, among many
others. The Annual Barry Reisberg Award
and Lecture Series honors an accomplished
clinician and researcher for distinguished
contributions to the field of non-pharmacologic
Alzheimer's disease treatment and care. The
award is named for Barry Reisberg, MD, Clinical
Director of New York University's Aging and
Dementia Research Center. Dr. Reisberg is a
psychiatrist, geriatric psychiatrist, and
psychopharmacologist whose research and practice
elegantly bridges all forms of treatment. Dr.
Reisberg received the Foundation's first award
in 2002. Past honorees include Dr. Jiska
Cohen-Mansfield, PhD, ABPP (2003), Cornelia
Beck, PhD, RN, FAAN (2004) and Ladislav Volicer,
M.D., PhD (2005).
Nominations for this award are welcomed from the
general public, professional colleagues, and
from the nominee her/himself. Please include a
one-page summary of previously published,
non-pharmacologic research with each nomination
and send it or email it to:
Hearthstone Alzheimer's Foundation
23 Warren Ave, Suite 140
Woburn, MA 01801
Attn: Sharon Johnson
Email:
Johnson@TheHearth.org
All submissions must be received by March 1st,
2006 for consideration. Finalists will be asked
to provide a complete CV and list of
publications. The honoree will be announced on
March 15th, 2006. The date in May for the Award
Ceremony will be arranged around the awardee's
schedule. The award comes with a $2,000
stipend and all travel expenses to New York City
for the award ceremony and lecture. This
award and lecture are jointly sponsored by The
Hearthstone Alzheimer's Family Foundation and
Forest Laboratories. The selection committee
will comprise previous award winners and
representatives from The Hearthstone Alzheimer's
Family Foundation.
RESEARCH
FELLOWSHIPS
(closing
date: 3 February 2006)
Up to 3 years
- stipend and support costs.
For completing
or recent PhDs with a well-defined research
proposal and a UK sponsor.
CLINICAL
RESEARCH FELLOWSHIPS
(closing
date: 3 February 2006)
Salary support
for up to 5 years for talented early career
clinical scientists with a high-quality research
program.
PILOT
PROJECT GRANTS
(Closing date: 17 March 2006)
Seed-corn funds
for small innovative research projects or pilot
studies, normally up to £30K for 6-24 months.
EQUIPMENT
GRANTS
(Closing date: 17 March 2006)
Applications
for research equipment (flexibly defined) for
£10K-£100K can be made at any time, and are
considered twice per year.
EMERGENCY SUPPORT GRANTS
NETWORK
CO-OPERATION GRANTS
Exclusive to
ART Network Members – applications at any time.
Doris Duke
Charitable Foundation Announces Distinguished
Clinical Research Award Competition
Deadline: February 14, 2006
A program of the Doris Duke Charitable
Foundation ( www.ddcf.org/), the Doris Duke
Distinguished Clinical Scientist Award
recognizes outstanding mid- career
physician-scientists who are applying the latest
scientific advances to the prevention,
diagnosis, treat- ment, and cure of disease and
who are wager to support and mentor the next
generation of physician-scientists conducting
clinical research.
In 2006, up to five grants of $1.5 million each
will be awarded to mid-career
physician-scientists conducting translational
clinical research in any disease area.
Awards must be used over at least a five-year
period.
All nominees must have received an M.D. from an
accredited institution in the United States
(holders of M.D./ Ph.D. degrees are also
eligible, as are holders of M.D.-equivalent
degrees from non-U.S. institutions); have a
full-time university faculty appointment at the
level of associate professor or above as of
February 14, 2006; have been appointed to their
first full-time, faculty- level position no
earlier than February 14, 1991 (all full-time
post-fellowship instructor-level positions will
be considered full-time faculty-level
appointments); and have an established
translational clinical research pro- gram (in
any disease area). Nomination packages
will be accepted from U.S. academic medical
centers and other U.S. nonprofit research
institutions. Visit the DDCF Web site to
download the 2006 Request for Nominations and/or
an eligibility FAQ.
back |
|
MEETING ANNOUNCEMENTS:
Have
a conference you want us to feature? Tell
us about it.
February 16-19, 2006
Berlin, Germany
7th International Conference on New
Trends in Immunosuppression and
Immunotherapy
mailto:immuno_reg@kenes.com
or visit
http://www.kenes.com/immuno.
March 15-19, 2006
Grand Cevahir Hotel, Istanbul,
Turkey
Middle East Congress On Aging,
presented by Turkish Geriatric
Foundation (TUGEV) and European
Federation of the Elderly Migrants (ERFEM).
mailto:erfem@erfem.org
or
mailto:info@meca2006.org
or visit
http://www.meca2006.org.
March 29-April 1, 2006
Palermo, Sicily
The 3rd International Conference on
Functional Genomics of Aging.
ga2006@elsevier.com
or visit
www.fga2006.elsevier.com
April 2-6, 2006
Istanbul, Turkey
The International Congress of Geriatrics
Society-Turkey, in collaboration
with the International Association of
Gerontology-IAG, European Union
Geriatric Medicine Society-EUGMS and
International Institute on Ageing-INIA.
Contact:
http://www.geriatrics2006.org.
April 7-8 , 2006
Montreal, Canada
The International Network of Integrated
Care (INIC) will hold its 2006
Annual Scientific Conference in Montreal
Canada-the first of its meetings in
North America.
http://www.integratedcarenetwork.org
April 26-28, 2006
Turkey
11th International Symposium on
Social and Applied Gerontology.
mailto:symposium@geroder.org
or visit
http://www.geroder.org/symp.
April 27-30, 2006
May 4-7, 2006
June 30-July 3, 2006
IPSI Conferences have issued an
invitation for papers to the IPSI
Transactions journal or to attend one of
the upcoming multidisciplinary,
interdisciplinary and transdisciplinary
conferences in Carcassone, France (April
27-30, 2006), S'Agaro, Costa Bravo,
Spain (May 4-7, 2006) and Montreal,
Canada (June 30-July 3, 2006). For
details, visit:
http://internetconferences.net/.
 September 16-20,
2006
The
5th European Congress of
Biogerontology
Istanbul, Turkey
www.biogerontology2006.org
Contact Professor Serif Akman, Chair
Email:
sakman@gata.edu.tr
Download announcement
here.
September 7-9, 2006
"The Ageing Jigsaw: Interdisciplinary
Approaches to Understanding Old Age",
35th Annual Scientific
Meeting of British Society of
Gerontology. Contact: +44 (0) 1248
382225 Fax: +44 (0) 1248 382229 or
mailto:csprd@bangor.ac.uk
or visit
http://www.bangor.ac.uk/csprd/bsg2006.htm.
October
13-15, 2006
Melbourne, Australia
3rd International Conference on
Healthy Ageing and Longevity. 3rd Annual
Scientific Meeting of the International
Research Centre for Healthy Ageing and
Longevity (IRCHAL). Co-sponsored by
the World Health Organization. Contact:
+61 3 9587 9190 Fax: +61 2 66 80 9643 or
mailto:info@longevity-international.com
or visit
http://www.longevity-international.com.
back
|
|
INTERVIEW:
"My Involvement in Aging Research Was just a
Series of Coincidences”
interview with Kenichi Kitani, by Sataro Goto
 The
American Aging Association is pleased to feature
an interview with Dr. Kenichi Kitani by Sataro
Goto, published in
Biogerontology. Dr. Kitani is a member of
the
AGE Editorial Board and a long
collaborator of the American Aging Association.
Kenichi Kitani
graduated from the School of Medicine at the
University of Tokyo in 1960 with an M.D. Seven
years later, he received his Ph D in Medical
Science from the same university. He was trained
in the 2nd Medical Department of the University
of Tokyo Hospital as a physician and specialized
in Gastroenterology and Hepatology. After
spending one year in Denmark (Rigshospital,
Copenhagen) and another 2 years at UCLA in the
USA (Associate Research Physician, Laboratory of
Nuclear Medicine and Radiation Biology), he was
appointed to the Tokyo Metropolitan Institute of
Gerontology (TMIG) in 1972 as Chief, Laboratory
of Clinical Physiology. After more than 20 years
at the TMIG, he became Professor and Director of
the Radioisotope Research Institute, Faculty of
Medicine, University of Tokyo in July 1992. He
had served as Founding Director General for the
National Institute for Longevity Sciences since
its inauguration in July 1995. He has published
more than 300 scientific papers including more
than 150 in the field of Gerontology and has
organized many international symposia on
Longevity Sciences.
The interview was published in Biogerontology.
We thank Springer for allowing us free access to
it.
Click here to read the
interview:
http://springerlink.metapress.com/link.asp?id=q783k446362777888
|
JOURNAL ANNOUNCEMENT:
 AGE's
27.2 is still freely available to everyone!
Click here to access it.
AGE's 27.3 is now published and available to all
AGE members!
If you are not an AGE member,
become a member today and get access
to ALL AGE issues!
For journal updates, please
bookmark the Association's
homepage
or visit the Springer
site at
www.springeronline.com/11357.
back
|
|
CLICK HERE TO DONATE $35 OR
MORE FOR 35 OF AGE'S SUCCESSFUL YEARS!! |
-
BECOME A MEMBER OR RENEW YOUR MEMBERSHIP
TODAY
AT:
|
|
If you feel
that this information has reached you in error,
or simply are no longer interested in receiving
our monthly announcements, please click on the
unsubscribe link below. We also welcome any
recommendations that you may have to insure our
communications with you meet your expectations.
Please email
ameraging@aol.com with your
recommendations.
To unsubscribe, send us a message to
ameraging@aol.com.
back |
|
0 |
|
